Write your message
Volume 19, Issue 3 (Iranian Journal of Breast Diseases 2026)                   ijbd 2026, 19(3): 37-51 | Back to browse issues page

Ethics code: IR.AJUMS.HGOLESTAN.REC.1404.038


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farzaneh M, Miri H, Cheraghzadeh M, Sasani N, Sasani M. Investigating the Effect of the Supernatant of Mesenchymal Stem Cells (MSCs) Derived from the Lung Tissue of Chicken Embryo on the Expression Levels of GLI2 and WNT4 Growth-Regulatory Genes in the Breast Cancer Cell Line (MCF-7). , ijbd. 2026; 19 (3) :37-51
URL: http://ijbd.ir/article-1-1234-en.html
1- Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Department of Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4- Department of Basic Sciences, Faculty of Veterinary Medicine, Chamran University of Ahvaz, Ahvaz, Iran
5- Department of Emergency Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Cancer, Environmental and Petroleum Pollutants Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , sasani-m@ajums.ac.ir
Abstract:   (554 Views)
Introduction: Mesenchymal stem cells (MSCs) can modulate the tumor microenvironment and influence cancer cell behavior by secreting various bioactive factors. This study aimed to investigate the effect of MSC-derived secretions from chick embryo lung tissue on the expression of the tumorigenic genes WNT4 and GLI2 and of inflammatory factors in a human breast cancer cell line (MCF-7).
Materials and Methods: In this in vitro experimental study, cells were isolated and cultured from 10-day-old chick embryo lung tissue. In the third passage, the supernatant (CM; conditioned medium) obtained from MSCs was collected, and its effect on MCF-7 cells was examined. After 48 hours, CM was collected and filtered. ELISA measured the levels of the inflammatory cytokines IL-6 and TNF-α, and qRT-PCR measured the levels of the WNT4 and GLI2 genes. For statistical comparisons between groups, an independent t-test was used. All analyses were performed using SPSS version 26, and 0.05 was considered the significance threshold.
Results: Treatment of MCF-7 cells with MSCs-CM resulted in a significant decrease in the expression of WNT4 (P=0.0034) and GLI2 (P=0.0007) genes in the treatment group compared to the control group. Also, the levels of IL-6 (P=0.0155) and TNF-α (P=0.0073) in the treatment group showed significant decreases.
Conclusion: MSCs-CM can exert inhibitory effects on cancer cells by downregulating key genes in tumorigenic signaling pathways and reducing inflammatory factors.
Full-Text [PDF 770 kb]   (203 Downloads)    
Type of Study: Research | Subject: molecular cell
Received: 2026/02/12 | Accepted: 2026/07/26 | Published: 2026/10/22

References
1. Singareeka Raghavendra A, Damodaran S, Barcenas CH, Fuqua SA, Layman RM, Tripathy D. Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer. CA: A Cancer Journal for Clinicians. 2026;76(1):e70055. doi:10.3322/caac.70055 [DOI:10.3322/caac.70055] [PMID]
2. Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Signal transduction and targeted therapy. 2025;10(1):49. doi: 10.1038/s41392-024-02108-4 [DOI:10.1038/s41392-024-02108-4] [PMID] [PMCID]
3. Li X, Zhang H, Yang H, Song Y, Zhang F, Wang A. Modifiable risk factors for breast cancer: insights from systematic reviews. Public Health Nursing. 2025;42(2):1060-71. doi:10.1111/phn.13504 [DOI:10.1111/phn.13504] [PMID]
4. Hui M, Cazet A, Nair R, Watkins DN, O'Toole SA, Swarbrick A. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Research. 2013;15(2):203. doi:10.1186/bcr3401 [DOI:10.1186/bcr3401] [PMID] [PMCID]
5. Gray A. Hedgehog signaling in Triple-Negative Breast Cancer: Effects on the Tumor Immune Microenvironment: University of Toronto (Canada); 2025. 31934138.
6. García-Martínez A, Pérez-Balaguer A, Ortiz-Martínez F, Pomares-Navarro E, Sanmartín E, García-Escolano M, et al. Hedgehog gene expression patterns among intrinsic subtypes of breast cancer: prognostic relevance. Pathology-Research and Practice. 2021;223:153478. doi:10.1016/j.prp.2021.153478 [DOI:10.1016/j.prp.2021.153478] [PMID]
7. Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosnian journal of basic medical sciences. 2018;18(1):8. doi:10.17305/bjbms. 2018.2756 [DOI:10.17305/bjbms.2018.2756] [PMID] [PMCID]
8. Cong G, Zhu X, Chen XR, Chen H, Chong W. Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer. Cell Death Discovery. 2025;11(1):40. doi:10.1038/s41420-025-02327-w [DOI:10.1038/s41420-025-02327-w] [PMID] [PMCID]
9. Jaremba EA, Beadle E, Rhoades J. Gli2 regulation of EMT in TNBC invasion. Cancer Research. 2026;86:4844. doi:10.1158/1538-7445.AM2026-4844 [DOI:10.1158/1538-7445.AM2026-4844]
10. Gray A, Shen Q, Marini W, Murakami K, Ohashi P, Reedijk M. Targeting tumoral GLI1 in triple-negative breast cancer: A novel strategy to reverse the immunosuppressive microenvironment. Cancer Research. 2026;86(7)173. doi:10.1158/1538-7445.AM2026-173 [DOI:10.1158/1538-7445.AM2026-173]
11. Chronopoulou E, Koika V, Tsiveriotis K, Stefanidis K, Kalogeropoulos S, Georgopoulos N, et al. Wnt4, Wnt6 and β-catenin expression in human placental tissue-is there a link with first trimester miscarriage? Results from a pilot study. Reproductive Biology and Endocrinology. 2022;20(1):51. doi:10.1186/s12958-022-00923-4 [DOI:10.1186/s12958-022-00923-4] [PMID] [PMCID]
12. Sottnik JL, Shackleford MT, Robinson SK, Villagomez FR, Bahnassy S, Oesterreich S, et al. WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers. Cancer Research Communications. 2024;4(1):134-51. doi:10.1158/2767-9764.CRC-23-0275 [DOI:10.1158/2767-9764.CRC-23-0275] [PMID] [PMCID]
13. Kurzava Kendall L, Ma Y, Yang T, Lubecka K, Stefanska B. Epigenetic effects of resveratrol on oncogenic signaling in breast cancer. Nutrients. 2024;16(5):699. doi:10.3390/nu16050699 [DOI:10.3390/nu16050699] [PMID] [PMCID]
14. Wong RSY, Tan EW, Goh BH. Mesenchymal stem cell-based therapies: challenges and enhancement strategies. Cell Biochemistry and Biophysics. 2026;84(1):131-47. doi:10.1007/s12013-025-01895-z [DOI:10.1007/s12013-025-01895-z] [PMID] [PMCID]
15. Warzycha M, Oleksiuk A, Suska O, Kolanowski TJ, Rozwadowska N. Engineered Mesenchymal Stromal Cells in Oncology: Navigating Between Therapeutic Delivery and Tumor Promotion. Genes. 2026;17(1):108. doi:10.3390/genes17010108 [DOI:10.3390/genes17010108] [PMID] [PMCID]
16. Garcia GL, Baruwal R, Suresh S, Britt AK, Li A, Atiya HI, et al. Mesenchymal stromal/stem cells in tumour initiation, progression and therapy. Nature Reviews Cancer. 2026, 26(8):604-619. doi:10.1038/s41568-026-00936-w [DOI:10.1038/s41568-026-00936-w] [PMID]
17. Chang Y-H, Wu K-C, Ding D-C. Extracellular Vesicles from Bone Marrow Mesenchymal Stem Cells Modulate Proliferation, Migration, and Chemosensitivity in Ovarian Cancer Cells. International Journal of Molecular Sciences. 2026;27(5):2468. doi:10.3390/ijms27052468 [DOI:10.3390/ijms27052468] [PMID] [PMCID]
18. Li Y, Gao X, Wang J. Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model. Experimental and Therapeutic Medicine. 2017;15:1839-46. doi:10.3892/etm.2017.5606 [DOI:10.3892/etm.2017.5606]
19. Ulldemolins A, Jurado A, Herranz-Diez C, Gavara N, Otero J, Farré R, et al. Lung Extracellular Matrix Hydrogels-Derived Vesicles Contribute to Epithelial Lung Repair. Polymers. 2022;14(22):4907. doi:10.3390/polym14224907 [DOI:10.3390/polym14224907] [PMID] [PMCID]
20. Visweswaran M, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines. The International Journal of Biochemistry & Cell Biology. 2018;95:63-72. doi:10.1016/j.biocel.2017.12.013 [DOI:10.1016/j.biocel.2017.12.013] [PMID]
21. Yu T, Cui Y, Xin S, Fu Y, Ding Y, Hao L, et al. Mesenchymal stem cell conditioned medium alleviates acute lung injury through KGF-mediated regulation of epithelial sodium channels. Biomedicine & Pharmacotherapy. 2023;169:115896. doi:10.1016/j.biopha.2023.115896 [DOI:10.1016/j.biopha.2023.115896] [PMID]
22. Canals J, Navarro A, Vila C, Canals JM, Díaz T, Acosta-Plasencia M, et al. Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines. Journal of Experimental & Clinical Cancer Research. 2022;41(1):37. doi:10.1186/s13046-021-02206-z [DOI:10.1186/s13046-021-02206-z] [PMID] [PMCID]
23. Pashaei-Asl R, Pashaiasl M, Ebrahimie E, Ataei ML, Paknejad M. Apoptotic effects of human amniotic fluid mesenchymal stem cells conditioned medium on human MCF-7 breast cancer cell line. BioImpacts : BI. 2022;13:191-206. doi:10.34172/bi. 2022.23813 [DOI:10.34172/bi.2022.23813] [PMID] [PMCID]
24. Harman RM, Churchill KA, Parmar S, Van de Walle GR. Mesenchymal stromal cells isolated from chicken peripheral blood secrete bioactive factors with antimicrobial and regenerative properties. Frontiers in Veterinary Science. 2022; 9:949836. doi:10.3389/fvets.2022.949836 [DOI:10.3389/fvets.2022.949836] [PMID] [PMCID]
25. Massah S, Foo J, Li N, Truong S, Nouri M, Xie L, et al. Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3. Molecular and Cellular Endocrinology. 2021;522:111136. doi:10.1016/j.mce.2020.111136 [DOI:10.1016/j.mce.2020.111136] [PMID]
26. Asadpour A, Cottrell GS, Widera D. Pro-and Anti-tumorigenic effects of MSC secretome in Glioblastoma: mechanisms and therapeutic implications. Stem cell reviews and reports. 2026:1-13. doi:10.1007/s12015-026-11082-z [DOI:10.1007/s12015-026-11082-z] [PMID] [PMCID]
27. Alpeeva EV, Ryabchenko AS, Vorotelyak EA. Characterization, preconditioning, safety, and other issues of MSC-derived EVs and secretome. International Journal of Molecular Sciences. 2026;27(4):1688. doi:10.3390/ijms27041688 [DOI:10.3390/ijms27041688] [PMID] [PMCID]
28. Hecker N, Kempynck N, Mauduit D, Abaffyová D, Vandepoel R, Dieltiens S, et al. Enhancer-driven cell-type comparison reveals similarities between mammalian and avian pallia. Science. 2025;387(6735):eadp3957. doi:10.1126/science.adp3957 [DOI:10.1126/science.adp3957] [PMID]
29. Ye Ge YG, Liang ChaiHong LC, Hua DengGuo HD, Song LeiYong SL, Xiang YangGuo XY, Guang Chen GC, et al. Phylogenetic analysis and pathogenicity assessment of two strains of avian influenza virus subtype H9N2 isolated from migratory birds: high homology of internal genes with human H10N8 virus. 2016. 7:57. doi:10.3389/fmicb.2016.00057 [DOI:10.3389/fmicb.2016.00057]
30. Farzaneh M, Attari F, Mozdziak P, Khoshnam S. The evolution of chicken stem cell culture methods. British poultry science 2017;58(6):681-6. doi:10.1080/00071668.2017.1365354 [DOI:10.1080/00071668.2017.1365354] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb